256 related articles for article (PubMed ID: 34378335)
1. Microphysiological systems in absorption, distribution, metabolism, and elimination sciences.
Van Ness KP; Cesar F; Yeung CK; Himmelfarb J; Kelly EJ
Clin Transl Sci; 2022 Jan; 15(1):9-42. PubMed ID: 34378335
[TBL] [Abstract][Full Text] [Related]
2. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
[TBL] [Abstract][Full Text] [Related]
4. Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).
Maass C; Stokes CL; Griffith LG; Cirit M
Integr Biol (Camb); 2017 Apr; 9(4):290-302. PubMed ID: 28267162
[TBL] [Abstract][Full Text] [Related]
5. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
[TBL] [Abstract][Full Text] [Related]
6. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
[TBL] [Abstract][Full Text] [Related]
7. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
[TBL] [Abstract][Full Text] [Related]
8. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
[TBL] [Abstract][Full Text] [Related]
9. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
[TBL] [Abstract][Full Text] [Related]
10. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
[TBL] [Abstract][Full Text] [Related]
12. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
Yamazaki D
Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
[TBL] [Abstract][Full Text] [Related]
13. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
Edington CD; Chen WLK; Geishecker E; Kassis T; Soenksen LR; Bhushan BM; Freake D; Kirschner J; Maass C; Tsamandouras N; Valdez J; Cook CD; Parent T; Snyder S; Yu J; Suter E; Shockley M; Velazquez J; Velazquez JJ; Stockdale L; Papps JP; Lee I; Vann N; Gamboa M; LaBarge ME; Zhong Z; Wang X; Boyer LA; Lauffenburger DA; Carrier RL; Communal C; Tannenbaum SR; Stokes CL; Hughes DJ; Rohatgi G; Trumper DL; Cirit M; Griffith LG
Sci Rep; 2018 Mar; 8(1):4530. PubMed ID: 29540740
[TBL] [Abstract][Full Text] [Related]
14. [Microphysiological system as a promising technology for drug assay].
Ishida S; Kanamori T
Nihon Yakurigaku Zasshi; 2019; 154(6):345-351. PubMed ID: 31787688
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal microphysiological systems.
Blutt SE; Broughman JR; Zou W; Zeng XL; Karandikar UC; In J; Zachos NC; Kovbasnjuk O; Donowitz M; Estes MK
Exp Biol Med (Maywood); 2017 Oct; 242(16):1633-1642. PubMed ID: 28534432
[TBL] [Abstract][Full Text] [Related]
17. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
Hughes DJ; Kostrzewski T; Sceats EL
Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
[TBL] [Abstract][Full Text] [Related]
18. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
Ribeiro AJS; Yang X; Patel V; Madabushi R; Strauss DG
Clin Pharmacol Ther; 2019 Jul; 106(1):139-147. PubMed ID: 30993668
[TBL] [Abstract][Full Text] [Related]
19. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
[TBL] [Abstract][Full Text] [Related]
20. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development.
Raasch M; Fritsche E; Kurtz A; Bauer M; Mosig AS
Adv Drug Deliv Rev; 2019 Feb; 140():51-67. PubMed ID: 29908880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]